Thymidylate Synthase Expression and Sensitivity to THYMITAQTM in Cancer Cell Lines
Author Information
Author(s): EJ Estlin, K Balmanno, AH Calvert, AG Hall, J Lunec, DR Newell, ADJ Pearson, GA Taylor
Primary Institution: University of Newcastle upon Tyne
Hypothesis
The study investigates the relationship between thymidylate synthase expression and sensitivity to THYMITAQTM in human leukaemia and colorectal carcinoma cell lines.
Conclusion
The study found that sensitivity to THYMITAQTM did not correlate with thymidylate synthase activity, protein, or mRNA levels in the tested cell lines.
Supporting Evidence
- A 20-fold variation in sensitivity to THYMITAQTM was found within the colorectal cell line panel.
- TS activity was linearly related to TS protein levels (r2 = 0.87, P < 0.0001).
- Two colorectal cell lines and one leukaemic cell line were intrinsically resistant to THYMITAQTM.
Takeaway
This study looked at how a specific drug affects cancer cells and found that the amount of a certain protein in the cells didn't predict how well the drug would work.
Methodology
The study measured thymidylate synthase activity, protein levels, and mRNA in various cancer cell lines and assessed their sensitivity to THYMITAQTM.
Limitations
The study did not account for potential mutations in thymidylate synthase that could affect drug sensitivity.
Participant Demographics
The study involved human colorectal carcinoma and leukaemia cell lines.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Want to read the original?
Access the complete publication on the publisher's website